Bitancor, Alexander C.

HRN: 22-11-62  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/25/2022
11/13/2022
IV
4.5g
Q6
Penunonia; Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaUnspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: